Trough concentrations of cyclosporine in blood following administration with grapefruit juice
- 1 November 1993
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 36 (5), 457-459
- https://doi.org/10.1111/j.1365-2125.1993.tb00395.x
Abstract
Components of grapefruit juice have been shown to inhibit CYP3A4 activity, the enzyme involved in cyclosporine metabolism. Eleven medically stable patients (seven males, four females) receiving cyclosporine following kidney transplantation were instructed to take their usual dose of cyclosporine with water for 1 week (Phase 1), with grapefruit juice (8 ounces) for 1 week (Phase 2) and again with water for 1 week (Phase 3). Trough blood samples were obtained at the end of each phase for measurement of cyclosporine concentration using a specific monoclonal whole blood radioimmunoassay. Cyclosporine trough concentrations averaged 116.9 +/- 51.6 ng ml(-1) in the first phase, 145.3 +/- 44.7 ng ml(-1) with grapefruit juice (P < 0.05 compared with the first and third phases) and 111.2 +/- 56.1 ng ml(-1) in the third phase. Cyclosporine concentrations increased in 8 of 11 patients when given with grapefruit juice (mean increase 32%; range -4 to 97%) and declined in 10 of 11 when subjects resumed taking cyclosporine with water (mean decrease 27%). These results suggest that grapefruit juice increases trough concentrations of cyclosporine in blood, possibly by inhibiting pre-hepatic gut wall metabolism, and could be useful in optimizing therapy with this drug.Keywords
This publication has 12 references indexed in Scilit:
- Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine ? and its potential clinical relevanceEuropean Journal of Clinical Pharmacology, 1992
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991
- Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humansClinical Pharmacology & Therapeutics, 1991
- Evidence for pre‐hepatic metabolism of oral cyclosporine in children.British Journal of Clinical Pharmacology, 1991
- The role of cytochromes P-450 in cyclosporine metabolismJournal of the American Academy of Dermatology, 1990
- In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoidsCarcinogenesis: Integrative Cancer Research, 1990
- Pharmacokinetic interaction between cyclosporin and diltiazemEuropean Journal of Clinical Pharmacology, 1990
- Cyclosporin‐erythromycin interaction in renal transplant patients.British Journal of Clinical Pharmacology, 1989
- Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.Journal of Clinical Investigation, 1987
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986